Cargando…
Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients
Acarbose is an α-glucosidase inhibitor that is commonly used to control postprandial blood glucose. It functions as a competitive and reversible inhibitor of small intestinal brush border glucosidase, blocks the degradation of starch and sucrose, and delays the absorption of glucose and fructose in...
Autores principales: | He, Ke, Shi, Jun-Cheng, Mao, Xiao-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085335/ https://www.ncbi.nlm.nih.gov/pubmed/25061309 http://dx.doi.org/10.2147/TCRM.S50362 |
Ejemplares similares
-
Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
por: Rosak, Christoph, et al.
Publicado: (2012) -
Insulin Glargine and Acarbose in the treatment of elderly patients with diabetes
por: Li, Jing, et al.
Publicado: (2019) -
Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes
por: Hanefeld, Markolf
Publicado: (2007) -
Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus
por: Wu, Honghua, et al.
Publicado: (2017) -
Evaluation of the Bioequivalence of Acarbose in Healthy Chinese People
por: Chen, Yan, et al.
Publicado: (2021)